NL190701C - Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride. - Google Patents

Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride.

Info

Publication number
NL190701C
NL190701C NL8000289A NL8000289A NL190701C NL 190701 C NL190701 C NL 190701C NL 8000289 A NL8000289 A NL 8000289A NL 8000289 A NL8000289 A NL 8000289A NL 190701 C NL190701 C NL 190701C
Authority
NL
Netherlands
Prior art keywords
furoyl
piperazinyl
dimethoxy
amino
preparation
Prior art date
Application number
NL8000289A
Other languages
English (en)
Dutch (nl)
Other versions
NL8000289A (nl
NL190701B (nl
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NL8000289A publication Critical patent/NL8000289A/nl
Publication of NL190701B publication Critical patent/NL190701B/xx
Application granted granted Critical
Publication of NL190701C publication Critical patent/NL190701C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NL8000289A 1979-01-31 1980-01-16 Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride. NL190701C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI790320A FI67699C (fi) 1979-01-31 1979-01-31 Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI790320 1979-01-31

Publications (3)

Publication Number Publication Date
NL8000289A NL8000289A (nl) 1980-08-04
NL190701B NL190701B (nl) 1994-02-01
NL190701C true NL190701C (nl) 1994-07-01

Family

ID=8512343

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8000289A NL190701C (nl) 1979-01-31 1980-01-16 Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-[4-(2-furoyl)-1-piperazinyl]chinazolinehydrochloride.

Country Status (21)

Country Link
US (1) US4271300A (mo)
JP (1) JPS55104280A (mo)
AT (1) AT374475B (mo)
BE (1) BE881297A (mo)
CA (1) CA1128945A (mo)
CH (1) CH644605A5 (mo)
CS (1) CS214692B2 (mo)
DD (1) DD148952A1 (mo)
DE (1) DE3002553A1 (mo)
DK (1) DK158352C (mo)
FI (1) FI67699C (mo)
FR (1) FR2447920A1 (mo)
GB (1) GB2041932B (mo)
HU (1) HU181016B (mo)
NL (1) NL190701C (mo)
NO (1) NO152298C (mo)
PL (1) PL126994B1 (mo)
SE (1) SE430692B (mo)
SU (1) SU900812A3 (mo)
YU (1) YU41498B (mo)
ZA (1) ZA80501B (mo)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AT384218B (de) * 1985-12-04 1987-10-12 Gerot Pharmazeutika Verfahren zur herstellung von neuen chinazolin-derivaten
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
GB1390015A (en) * 1971-05-07 1975-04-09 Koninklijke Pharma Fab Nv 4-amino-quinazoline compounds
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI58125C (fi) * 1976-12-15 1985-01-02 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan
FI58124C (fi) * 1976-12-15 1980-12-10 Orion Yhtymae Oy Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan

Also Published As

Publication number Publication date
DK158352C (da) 1990-10-08
NO152298B (no) 1985-05-28
DK42680A (da) 1980-08-01
US4271300A (en) 1981-06-02
DE3002553A1 (de) 1980-08-07
NO794279L (no) 1980-08-01
PL221684A1 (mo) 1980-10-20
DE3002553C2 (mo) 1988-10-27
YU5880A (en) 1983-02-28
NL8000289A (nl) 1980-08-04
HU181016B (en) 1983-05-30
DD148952A1 (de) 1981-06-17
FI790320A7 (fi) 1980-08-01
CH644605A5 (de) 1984-08-15
ZA80501B (en) 1981-02-25
BE881297A (fr) 1980-05-16
SE8000777L (sv) 1980-08-01
FI67699C (fi) 1985-05-10
JPS6310955B2 (mo) 1988-03-10
SU900812A3 (ru) 1982-01-23
CA1128945A (en) 1982-08-03
FI67699B (fi) 1985-01-31
JPS55104280A (en) 1980-08-09
GB2041932B (en) 1982-10-27
AT374475B (de) 1984-04-25
PL126994B1 (en) 1983-09-30
FR2447920A1 (fr) 1980-08-29
CS214692B2 (en) 1982-05-28
SE430692B (sv) 1983-12-05
NL190701B (nl) 1994-02-01
ATA19580A (de) 1983-09-15
FR2447920B1 (mo) 1982-12-03
DK158352B (da) 1990-05-07
YU41498B (en) 1987-08-31
GB2041932A (en) 1980-09-17
NO152298C (no) 1985-09-04

Similar Documents

Publication Publication Date Title
NL189127C (nl) Werkwijze voor de bereiding van 1,1-diesters.
NL7807432A (nl) Werkwijze voor het bereiden van 1,2,4-triazine-5-on-de- rivaten.
NL191313B (nl) Werkwijze voor de bereiding van p-chlooralkylbenzeen.
NL7802824A (nl) 11,12-seco-prostaglandinen alsmede werkwijze voor het bereiden daarvan.
NL7806658A (nl) Werkwijze voor de bereiding van 7,8-dihydro- 14-hydro- xynormorfine.
NL7706056A (nl) Werkwijze voor de bereiding van 5,6-cis- en 5,6-trans-10,19-dihydrovitamine d derivaten.
NL181923B (nl) Werkwijze voor de bereiding van beta-aminopropionamide.
FI801033A7 (fi) Menetelmä 2,6-diaminonebulariinien valmistamiseksi.
NL7808881A (nl) Werkwijze voor de bereiding van 1,1,1,2-tetrafluore- thaan.
NL190701B (nl) Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)chinazolinehydrochloride.
NL7707639A (nl) Werkwijze voor de bereiding van oxocyclopen- tyl- en oxocyclohexylverbindingen.
NO901631D0 (no) Fremgangsmaate for fremstilling av 2-substituerte n,n'-ditrimetoksybenzoyl-piperaziner.
NL8004231A (nl) Werkwijze voor het bereiden van 7-alkoxycarbonyl-6, 8-dimethyl-4-hydroxymethyl-1-fthalazon en tussenprodukten daarvan.
NL189132B (nl) Werkwijze voor het bereiden van 2-(4-(2-furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxychinazoline.
NL7702823A (nl) Werkwijze voor de bereiding van 2-(2,2-dicy- clohexylethyl)piperidine.
NL7614574A (nl) Werkwijze voor de bereiding van 3,4-dihydro- -2(1h)-chinazolinederivaten.
NL7804406A (nl) Werkwijze voor de bereiding van 1.2-dichloorethaan.
NL7810456A (nl) Werkwijze voor het bereiden van 6,11-dihydro-11-oxodi- benz (b,e)-oxepine-2-azijnzuur en tussenprodukten daarvoor.
NL172543C (nl) Werkwijze voor het bereiden van 2-Ÿ4-(2-furoyl)-piperazin-1-ylŸ -4-amino-6,7-dimethoxychinazoline of zijn hydrochloride of hydrobromide.
NL7808571A (nl) 2,3-polymethyleen-4-oxo-4h-pyrido/1,2-a/pyrimidinen en werkwijze voor de bereiding daarvan.
NL7901164A (nl) Werkwijze voor het bereiden van beta-santalol, beta-santaleen, dihydro-beta-santalol en verwante verbindingen.
NL7803465A (nl) Werkwijze voor het bereiden van 2-(2',2',2'- -trihalogeenethyl)-4-halogeencyclobutan-1-onen alsmede van cyclopropaancarbonzuurderivaten.
NL7706640A (nl) Werkwijze voor de bereiding van 2,9-dioxatri- cyclo(4,3,1,03-,7)decanen.
NL7806321A (nl) Piperazinecarbodithiozuurderivaten, werkwijze voor de bereiding daarvan en geneesmiddelen daaruit.
NL8001205A (nl) Spectinomycine-analoga, werkwijze voor het bereiden daarvan en daaruit bereide farmaceutische preparaten.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V1 Lapsed because of non-payment of the annual fee

Effective date: 19960801